NEW SERVICE
Join our new priority response service
INSIGHT ARTICLE
Complex regulatory challenges for lab grown ingredients
New QP loyalty scheme launched
Quality
Sustainability
Diversity & Inclusion
Community
Awards
Current vacancies
Early careers
Contact Us
Insights & resources
Whether it is a novel molecule or a biosimilar, your biopharmaceutical product will require GMP lot release testing with validated assays before it can be released to the clinic, to ensure patient safety.
At RSSL, our biopharmaceutical experts can offer validatable solutions to confirm the identity, purity, biosafety, concentration and potency of your molecule for release.
Parameter: Quality, integrity
Method: Pharmacopeia
Parameter: Identity, integrity
Method: Peptide map (UV or MS)
Method: Glycan mapping, monosaccharides, eg. HPLC
Parameters: Purity, integrity
Method: SEC, DLS
Parameters: Safety, impurity
Method: HCP-ELISA, PCR or dye assay for DNA, PCR for mycoplasma
Method: Karl Fisher
Parameters: Concentration
Method: UV+ scan, AAA
Parameter: Safety
Method: Impurity dependent
Parameters: Identity, purity, integrity
Method: IEF, IEX
Method: SDS-PAGE, CE-SDS, RP-HPLC, SEC
Method: RP-HPLC, IEF, IEX, peptide mapping (UV or MS)
Methods: Pharmacopeia methods, sub-vis
Parameters: Potency, quality, concentration, identity
Method: ELISA
Parameters: Safety
Method: Bioburden, sterility, endotoxin
Many proteins and bioactive peptides, including insulins, somatropin, teriperitide, exenatide, erythropoietin, albumin, follitropin and interferon, have their own specific monographs in various pharmacopeia worldwide. RSSL's biopharmaceutical experts are able to support you with an extensive range of pharmacopoeial testing.
Switchboard: +44 (0)118 918 4000
Customer Services: +44 (0)118 918 4076
We value your trust when sharing your personal data with us. We always treat your data in a fair and respectful manner limited to the purpose above mentioned. If you would like to know more about how we handle your data, please read our privacy notice.